Validated, tissue-specific library enables customisable and controllable liver-targeted gene expression with high specificity and minimal off-target activity in muscle tissue ...
Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Geminiâ„¢, a ...
Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...
Creative Biolabs, a leader in viral vector engineering and immunotherapy solutions, has announced the expansion of its ...
A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated ...
AZoLifeSciences on MSN
Proteomics approaches to overcome undruggable targets in disease
This proteomics-driven approach to drug discovery improves target validation and uncovers insights into undruggable proteins, ...
International actors funding Digital Public Infrastructure in post-conflict societies risk creating surveillance systems ...
Beijing, Feb. 06, 2026 (GLOBE NEWSWIRE) -- WiMi Releases Hybrid Quantum-Classical Neural Network (H-QNN) Technology for Efficient MNIST Binary Image Classification ...
The efficacy of adeno-associated virus (AAV)-mediated gene therapy for the inner ear is fundamentally constrained by the natural tropism of viral ...
Enrollment for 4FRONT-1, the first registrational trial for 4D-150 in wet AMD, was completed within an approximately 11-month period, ahead of ...
Guggenheim Securities Emerging Outlook: Biotech Summit 2026 February 12, 2026 12:30 PM ESTCompany ParticipantsR.
A Phase 3 clinical trial testing SGT-003, a gene therapy candidate for Duchenne muscular dystrophy (DMD), will start dosing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results